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Most viruses with non-segmented single stranded RNA genomes complete their life
cycle in the cytoplasm of infected cells. However, despite undergoing replication in the
cytoplasm, the structural proteins of some of these RNA viruses localize to the nucleus at
specific times in the virus life cycle, primarily early in infection. Limited evidence suggests
that this enhances successful viral replication by interfering with or inhibiting the host
antiviral response. Nucleocapsid proteins of RNA viruses have a well-established,
essential cytoplasmic role in virus replication and assembly. Intriguingly, nucleocapsid
proteins of some RNA viruses also localize to the nucleus/nucleolus of infected cells.
Their nuclear function is less well understood although significant advances have been
made in recent years. This review will focus on the nucleocapsid protein of cytoplasmic
enveloped RNA viruses, including their localization to the nucleus/nucleolus and function
therein. A greater understanding of the nuclear localization of nucleocapsid proteins has
the potential to enhance therapeutic strategies as it can be a target for the development
of live-attenuated vaccines or antiviral drugs.
Keywords: enveloped RNA viruses, nucleocapsid protein, nuclear localization, nucleolar localization, antiviral
responses
Introduction
The nucleocapsid protein of RNA viruses is essential for virus assembly, encapsidating
the genomic RNA in preparation for packaging in the virion (Hunter, 2007). In positive
strand RNA viruses (PSVs), the capsid or nucleocapsid protein is the major, often the only
structural protein. In negative strand RNA viruses (NSVs), the nucleocapsid protein has an
essential role in viral replication and transcription (Whelan, 2013) in addition to its role
in assembly. For most enveloped RNA viruses, both replication and assembly occur in the
cytoplasm (with the exception of orthomyxovirus, bornavirus, retroviruses, and hepatitis delta
virus whose replication occurs in the nucleus; Whelan, 2013). Interestingly, the nucleocapsid
protein (variously named N, NP, NC, or C protein) of many cytoplasmic RNA viruses
(PSVs and NSVs) transiently localizes to the nucleus and/or nucleolus. There is limited
information about the nuclear function of cytoplasmic RNA virus nucleocapsid proteins,
but evidence suggests supporting roles in successful viral replication by interfering with or
inhibiting the host antiviral response (Ahmed and Lyles, 1998; Ahmed et al., 2003; Lee
et al., 2006; Takayama et al., 2012) as has been described for several RNA virus structural
proteins.
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The nucleocapsid protein of mouse hepatitis virus
(MHV, Coronaviridae) and infectious bronchitis virus (IBV,
Coronaviridae) localizes to the nucleolus of infected cells
where it may regulate/delay cell cycle progression (Wurm
et al., 2001), while nuclear localization of vesicular stomatitis
virus (VSV, Rhabdoviridae) M, rabies (Rhabdoviridae) P, and
Measles virus (MV, Paramyxoviridae) N protein (Ahmed
et al., 2003; Schnell et al., 2010; Takayama et al., 2012) is
associated with the pathogenesis of viral infection. Nuclear
localization of the nucleocapsid protein of porcine respiratory
and reproductive syndrome virus (PRRSV, Arteriviridae) appears
to be essential for optimal virus replication and inhibition of
cellular antiviral processes (Lee et al., 2006); in an analogous
fashion, the successful production of infectious progeny of
respiratory syncytial virus (RSV, Paramyxoviridae) and Nipah
virus (Paramyxoviridae) requires nuclear localization of the
matrix (M) protein (Ghildyal et al., 2005, 2009; Wang et al.,
2010).
The aim of this review is to summarize current literature
on the role of nuclear/nucleolar localization of nucleocapsid
proteins of cytoplasmic PSVs and NSVs, which may lead to
similar investigations in other related virus families. Most of
our knowledge in this area derives from studies of viruses
belonging to the Coronaviridae, Arteriviridae, Flaviviridae, and
Paramyxoviridae families and these will be the main focus
(Table 1), with reference to other virus families when required.
Coronaviridae and Arteriviridae are classiﬁed together into the
order Nidovirales; for the sake of simplicity and due to the close
relationship among these viruses, both families will be discussed
together.
The location of the nucleocapsid gene within the genome
of selected viruses from the named families is shown in
Figure 1. The nucleocapsid [N, NC, or C (core or capsid)]
gene is in the ﬁrst position (3′ end) in Paramyxovirus genomes
and (5′ end) in Flavivirus and Hepacivirus genomes. The
nucleocapsid gene of Coronavirus and Arterivirus is in the last
position (3′ end) of these genomes, but the ﬁrst gene to be copied
into a negative sense subgenomic mRNA template for mRNA
transcription.
The Cytoplasmic Role of RNA Virus
Nucleocapsid Protein
The nucleocapsid protein of RNA viruses is a structural protein
found in a complex with the genomic RNA. The role of
genome encapsidation varies across PSVs and NSVs, but usually
comprises one or more of the following functions; [1] to
protect the genome from cellular nucleases, [2] to form the
ribonucleoprotein transcriptase complex, and [3] to package the
genome into new infectious particles prior to budding.
Nucleocapsid Protein of NSVs
The NSV nucleocapsid protein protects genomic viral RNA
against ribonuclease degradation and high salt concentration, as
well as maintaining the rigidity of the RNA structure following
cycles of folding/dissociation/refolding during the replication
cycle (Lynch and Kolakofsky, 1978; Mir and Panganiban,
2006; Raymond et al., 2010). The nucleocapsid protein is the
driving force for the formation of ribonucleoprotein (RNP)
complexes that are the replicative/transcriptive unit, as well as
for assembly and packaging into the virion. These functions
are facilitated through its propensity to self-associate and ability
to interact with other RNP components, including RNA and
viral polymerase subunits (Becker et al., 1998; DiCarlo et al.,
2007; Green et al., 2011; Sun et al., 2012). Nucleocapsid protein
has an inherent ability to interact with the phosphoprotein
(P; polymerase subunit and cofactor). This interaction is
particularly important because association between nucleocapsid
and RNA is not speciﬁc; instead, speciﬁcity is conferred via
the nucleocapsid-phosphoprotein interaction, such that RNA
associated with the nucleocapsid-phosphoprotein complex is
the form recognized by RNA polymerase (Myers et al., 1999;
Longhi, 2009). Additionally, the NSV phosphoprotein acts
as a chaperone for the nucleocapsid protein restricting non-
speciﬁc encapsidation of non-viral RNA (Curran et al., 1995;
Errington and Emmerson, 1997). The nucleocapsid protein
of VSV, in association with the P protein, is required for
genome encapsidation and transcription (Zhang et al., 2008;
Morin and Whelan, 2014) with mutations in its C-terminus
resulting in reduction of viral particle production in cell
culture (Heinrich et al., 2012). In RSV and Sendai virus
(Paramyxoviridae), it is the N-terminal of the nucleocapsid
protein that plays a similar role in genome encapsidation
(Buchholz et al., 1993; Myers and Moyer, 1997; Khattar et al.,
2000).
The Nucleocapsid/Capsid/Core Protein of
PSVs
Similar to the NSV nucleocapsid protein, the nucleocapsid/
capsid/core protein of PSVs binds tightly to the genomic RNA,
drives RNA packaging and sometimes, serves as a nucleic
acid chaperone. Flavivirus (Flaviviridae) C protein plays an
important role during assembly and budding of infectious
particles. Mutations in C protein lead to the inhibition of
infectious particle release while causing increased production of
defective particles (Jones et al., 2011). The hepatitis C virus (HCV,
Flaviviridae) core protein and the N protein of coronaviruses
severe acute respiratory syndrome coronavirus (SARS-CoV)
and transmissible gastroenteritis virus (TGEV) are potent RNA
chaperones that can resolve RNA misfolding and promote
annealing of complementary sequences (Rajkowitsch et al., 2007;
Zuniga et al., 2007; Sharma et al., 2010). Most of the evidence
for chaperone activity is derived from in vitro investigations and
although these proteins clearly have the ability to function as
RNA chaperones, the importance of this function in infection is
not clear.
Non-Encapsidation Roles of
Nucleocapsid Proteins
The N/NC/C proteins of both NSVs and PSVs have functions
in addition to their RNA stabilizing, encapsidating and, in
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TABLE 1 | Classification of enveloped RNA viruses discussed in the review.
Family Sub-family Genus Species
Flaviviridae Flavivirus Dengue virus, Japanese Encephalitis virus (JEV), West Nile virus
Hepacivirus Hepatitis C virus
Coronaviridae Coronavirinae Alphacoronavirus Transmissible gastroenteritis virus (TGEV)
Betacoronavirus Severe acute respiratory syndrome coronavirus (SARS-CoV), mouse hepatitis
virus
Gammacoronavirus Infectious bronchitis virus
Arteriviridae Arterivirus Lactose dehydrogenase elevating virus, Equine arterivirus, Porcine respiratory
and reproductive syndrome virus
Paramyxoviridae Paramyxovirinae Morbillivirus Measles virus, Canine distemper virus (CDV), Rinderpest virus
Henipavirus Nipah virus
Respirovirus Sendai virus
Pneumovirinae Pneumovirus Respiratory syncytial virus
the case of NSVs, viral transcriptase activities. The ﬂavivirus
core protein interacts with several host cell proteins and is
implicated in disease development through its roles in apoptotic
pathways as well as regulation of the innate immune response
(Urbanowski et al., 2008). Similarly, the coronavirus N protein
interferes with cellular antiviral responses (McBride et al., 2014).
The N protein of morbilliviruses (Paramyxoviridae) has been
shown to regulate interferon signaling via interference with the
signal transducer and activator of transcription (STAT) signaling
pathway (Takayama et al., 2012). Increasing literature suggests
that at least some of the non-encapsidating functions of the
nucleocapsid proteins of NSVs and PSVs derive from their ability
to localize to the nucleus or nucleolus of the infected cells.
FIGURE 1 | The position of nucleocapsid protein in the genome of
selected enveloped RNA virus families. Genomes of the named virus
families are indicated schematically with each gene indicated by a box with
family name, genome type and length indicated above each schematic. The
gene for nucleocapsid protein (N or C) is indicated by a gray box, other
structural proteins are indicated by white boxes and non-structural proteins
are indicated by hashed boxes. Lr, leader; Tr, trailer.
Nuclear Localization of Nucleocapsid
Proteins of RNA Viruses
Despite undergoing replication in the cytoplasm, the
nucleocapsid protein of several NSVs and PSVs localizes in
the nucleus or nucleolus of infected cells during infection.
This nuclear localization usually takes place early in the
infectious cycle as soon as the nucleocapsid protein is translated,
possibly to perform non-structural functions, followed by
return to the cytoplasm in the late stage of infection to
participate in assembly (Tijms et al., 2002; Yoo et al., 2003;
Sato et al., 2006). Although some progress has been made
in our understanding of the nucleocytoplasmic shuttling
of several nucleocapsid proteins, thus far, no deﬁnitive
single molecule studies have been undertaken; such studies
will be important to elucidate the ﬁner details of nuclear
transport pathways in the future.
Nucleocytoplasmic Transport
Eukaryotic cells sequester their genome in the nucleus, which is
surrounded by the double lipid bilayer structure of the nuclear
envelope (NE). The only avenue for transport into and out of
the nucleus is via the NE-embedded nuclear pore complexes
(NPCs) that are made up of over 40 diﬀerent proteins called
nucleoporins (Nups). Although diﬀusion of molecules <55 kDa
can occur, most transport through the NPC is mediated by
members of the importin superfamily, which recognize nuclear
localization sequences (NLSs) or nuclear export sequences
(NESs) on cargo molecules for transport into and out of the
nucleus, respectively (Ghildyal et al., 2005, 2009; Cardarelli et al.,
2008; Cohen et al., 2011). NLSs are usually short stretch(es) of
basic residues (monopartite NLS, e.g., that of the simian virus
40 T antigen) which may be separated by 10–15 amino acids
(bipartite NLS, e.g., that of nucleophosmin), while the most well
characterized NES is the Leucine-rich motif recognized by the
exportin CRM-1 (e.g., the NES in HIV Rev protein). Importins
function by binding NLSs and docking transiently at various
“FG” (Phenylalanine–Glycine repeat containing) Nups within the
NPC to eﬀect translocation through it, followed by release within
the nucleus facilitated by the guanine nucleotide binding protein
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Ran (Gorlich and Kutay, 1999). The best studied nuclear import
pathway is mediated by the importin-α/β1 heterodimer, where
importin-α recognizes and directly binds to the NLSs of the cargo,
and importin-β1 mediates binding of the import complex to
Nups (Macara, 2001). However, nuclear import can be eﬀected
by direct action of importin-β1 or homologs thereof, without a
requirement for importin-α (Fulcher and Jans, 2011). In all cases,
release within the nucleus occurs through binding of Ran, in its
guanosine triphosphate (GTP)-bound form, to importin-β1, or
homologs, to eﬀect dissociation of the import complex. Nuclear
export is analogous to nuclear import, wherein cargo molecules
containing NESs bind importin-β homologs, such as CRM-1, in
complex with Ran in its GTP bound state and are transported
out of the nucleus; release in the cytoplasm is facilitated by Ran
hydrolysis of GTP to guanosine diphosphate (GDP), which leads
to dissociation of the export complex (Macara, 2001).
Localization to the nucleolus is less well deﬁned, but is most
likely regulated by cargoes interacting with nucleolar residents,
possibly the so-called hub proteins (Emmott and Hiscox, 2009).
Nucleolar localization signals (NoLSs), similar to NLSs, are
short stretches of basic proteins, however, there is a high
level of variability in the NoLSs described to date (de Melo
et al., 2013). NoLSs are not capable of directing cargo into the
nucleus, although very often they overlap the NLS sequences.
Interestingly, CRM-1 has been shown to play an important
role in nucleolar localization of small nuclear and nucleolar
RNA molecules via complex binding mechanisms that lead to
masking/unmasking of the NoLS (Verheggen and Bertrand,
2012).
Coronaviridae and Arteriviridae
Viruses in the Coronaviridae family possess a positive (+) ssRNA
genome and cluster into two subfamilies including Coronavirinae
which includes the human coronaviruses, and six genera. The
viruses ofArteriviridae family are also positive (+) ssRNA viruses
and grouped into one genus, Arterivirus.
The nucleocapsid proteins of viruses belonging to genus
Arterivirus localize to the nucleus, as has been shown for lactate
dehydrogenase-elevating virus (LDV; Mohammadi et al., 2009),
equine arteritis virus (EAV; Tijms et al., 2002) and PRRSV
(Rowland et al., 1999). Nuclear import of the LDV nucleocapsid
protein is facilitated by a monopartite NLS motif, 38KKKK41
(Figure 2A), probably mediated by the importin-α/β complex
(Mohammadi et al., 2009), and whilst the EAV nuclear import has
not been clearly deﬁned, nuclear export is facilitated by CRM-1
(Tijms et al., 2002). PRRSV nucleocapsid protein possesses NLS,
nucleolar retention/localization signal (NoRS/-LS), and NES
motifs that facilitate independent nucleocytoplasmic transport
and accumulation in the nucleoli of infected cells (Rowland et al.,
1999; Yoo et al., 2003). The NLS motifs that are located in
amino acid residues 10–13 (NLS1) and 41–47 (NLS2) facilitate
nuclear import via interaction with importin-α/β, while the NES
motif is located in amino acid residues 106–117 and works with
CRM-1 to facilitate nuclear export (Pei et al., 2008). Disruption
of nuclear/nucleolar localization of PRRSV nucleocapsid protein
has been shown not to aﬀect the capability to produce infectious
particles in MARC-145 cells (monkey kidney cells permissive
FIGURE 2 | Nuclear/nucleolar transport signals in nucleocapsid
proteins of Arteriviridae and Coronaviridae. The nucleocapsid proteins of
representatives of named virus families are shown schematically. Numbers
under the schematics indicate position of amino acid residues, nuclear
localization signals (NLSs) are indicated by solid black filled boxes, nuclear
export signals (NESs) are indicated by hatched boxes and nucleolus
localization/retention signals (NoLS/RS) are indicated by black open boxes.
The sequence of the transport signals is shown in single letter format, with
essential residues in bold; sequences in italics are predicted but not yet
confirmed. (A) Arteriviridae: LDV, lactate dehydrogenase virus; EAV, equine
arteritis virus; PRRSV, porcine respiratory and reproductive syndrome virus.
(B) Coronaviridae: Broken black line indicates predicted NoLS/RS. IBV,
infectious bronchitis virus; TGEV, transmissible gastroenteritis virus; MHV,
mouse hepatitis virus; SARS-CoV, severe acute respiratory syndrome
coronavirus.
to PRRSV infection), however, it did result in attenuated viral
replication and induced a higher titer of neutralizing antibody in
pigs. This suggests the nucleocytoplasmic localization of PRRSV
nucleocapsid protein has an important role in pathogenesis of
PRRSV infection (Lee et al., 2006; Pei et al., 2008).
Nucleocapsid proteins of coronaviruses IBV and MHV
localize to the nucleolus of infected cells facilitated by NLSs,
NoRS/-LS, and an NES (Hiscox et al., 2001; Wurm et al.,
2001; Chen et al., 2002; Reed et al., 2006; Figure 2B). In the
nucleolus the nucleocapsid protein may modulate cell division,
as evidenced by the fact that cells expressing coronavirus
nucleocapsid protein appear to be arrested in the G2/M phase of
the cell cycle (Chen et al., 2002; Ding et al., 2014a; McBride et al.,
2014). Delay in the cell cycle may promote conditions suitable for
virus replication and assembly.
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The nucleocapsid protein of IBV has been shown to associate
with ﬁbrillarin and nucleolin in the nucleolus (Hiscox et al.,
2001). In particular, as also observed for MHV and TGEV
nucleocapsid proteins, it causes G2 arrest of the cell cycle
that leads to reorganized ﬁbrillarin distribution, where the
interaction and/or redistribution are associated with a delay in
cell growth (Hiscox et al., 2001; Chen et al., 2002; Ding et al.,
2014a).
The nucleolus is a multifunctional nuclear substructure
that is central to the normal operations of a cell, with
important roles in ribosome synthesis and assembly, cell cycle
regulation, transcription regulation, cell senescence and sensing
and response to stress (Bartova et al., 2010; Shaw and Brown,
2012; Golomb et al., 2014). The nucleolar proteome consists
of more than 500 proteins identiﬁed so far; some are long
term residents, while others shuttle between the nucleolus,
nucleoplasm, cytoplasm, and cell membrane (Andersen et al.,
2002; Lam et al., 2005) depending on the metabolic state of
the cell. Fibrillarin, nucleolin, and nucleophosmin are major
nucleolar proteins that have been studied extensively. Fibrillarin
is involved in many post-transcription processes and ribosome
assembly; nucleolin serves crucial roles in pre-rRNA processing
and may regulate transcription; nucleophosmin is implicated
in ribosome assembly, nucleocytoplasmic shuttling and may
regulate rDNA transcription [(Hiscox, 2002) and references
therein].
The SARS-CoV nucleocapsid protein is predominantly
cytoplasmic in infected cells and in cells transfected to express the
full length protein. Interestingly, the protein sequence contains
three putative NLSs and a putative NES (Figure 2B); the latter
is non-functional (You et al., 2005, 2007). A bipartite NLS
and putative NoLS appear to be functional but are masked in
the context of the full length protein by a dominant CRM-
1-independent NES in the C-terminus. Additionally, SARS
CoV nucleocapsid cytoplasmic localization is facilitated by
interaction with 14-3-3 (tyrosine 3-monooxygenase/tryptophan
5-monooxygenase activation protein; Macara, 2001; Surjit et al.,
2005). Thus, the SARS-CoV nucleocapsid protein, to the best of
our knowledge, does not localize to the nucleus or the nucleolus
of infected cells, in contrast to the nucleocapsid proteins of other
coronaviruses studied.
Paramyxoviridae
Nucleocapsid proteins of some viruses in the Paramyxoviridae
family have been shown to undergo transient nuclear localization.
The nucleocapsid proteins of canine distemper virus (CDV) and
rinderpest virus (RPV) possess conserved NLS and NES motifs;
the NES is CRM-1 independent, despite being a Leucine-rich
motif (Sato et al., 2006; Figure 3). MV infected cells contain
nuclear inclusion bodies (composed of N, phosphoprotein and
large polymerase; Robbins and Eagle, 1985). More importantly,
the nuclear translocation of MV nucleocapsid protein also aﬀects
the host immune response by inhibiting the nuclear translocation
of STATs, causing disruption of the IFN-α/β and IFN-γ signaling
pathways (Takayama et al., 2012). The NLS motif is contained
within 70TGILISILSLF80; while the NES is contained within
residues 425SENELPRLGGKEDRRV440 (Sato et al., 2006).
FIGURE 3 | Nuclear transport signals in nucleocapsid proteins of
Paramyxoviridae. The NLSs and NESs are indicated as in Figure 2;
a dashed-line box with dots indicates flanking sequences that have been
shown to have a role in nuclear import and retention. CDV, canine distemper
virus; RPV, Rinderpest virus; MV, measles virus.
FIGURE 4 | Nuclear localization signals in C (capsid or core) proteins
of Flaviviridae. The NLSs for each viral protein and the NES for HCV are
indicated as in Figure 2. DENV-2, Dengue virus serotype 2, KV, Kunjin virus;
WNV, West Nile virus; JEV, Japanese encephalitis virus; HCV, hepatitis C virus.
Flaviviridae
The capsid (C) protein of several members of the Flaviviridae
family localize to the nucleus of infected cells using NLSs
(Figure 4). The Flavivirus C protein is small enough to diﬀuse
across the NE; however, studies have shown that it utilizes active
nuclear transport pathways to localize to the nucleus.
The C protein of Dengue virus localizes to the nucleus of
infected mammalian cells, starting at 6 h post-infection (h.p.i)
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and remains at high levels throughout the course of infection
(up to 72 h.p.i; Sangiambut et al., 2008). The C protein does
not localize to the nucleus of mosquito cells, possibly due
to the diﬀerent availability of carrier proteins or the cellular
components involved in nuclear translocation.
The C (core) protein of the Japanese encephalitis virus (JEV)
has been shown to localize into the nucleus and associate with
the phosphoprotein B23 in the nucleolus (Tsuda et al., 2006).
The nuclear localization is required for successful replication in
mammalian cell lines and is determined by amino acid residues
42GP43 of the NLS, with G42 being the major determinant
(Mori et al., 2005). 42GP43substitution into A42−43 eliminates the
nuclear localization ability in both mosquito and mammalian cell
lines and decreases infectious virus production in mammalian
cell lines and in infected mice. The GP motif is conserved in
Dengue, Kunjin, and Hepatitis C virus C proteins (Mori et al.,
2005).
Hepatitis C virus C protein has been found in the nucleus
in the C-terminally truncated form, particularly in hepatocytes
isolated from chronic HCV patients (Falcon et al., 2003),
suggesting a possible role in persistence of HCV infection, which
often leads to hepatocellular carcinoma. The nuclear localization
of HCV C is dependent on importin-α, which recognizes NLS
motifs contained within the residues 5–13 (PKPQRKTKR),
38–43 (PRRGPR), and 58–71 (PRGRRQPIPKARRP;
Suzuki et al., 2005). HCV C also has a functional CRM-1
dependent NES in residues 109–133 (Cerutti et al., 2011).
The nuclear localization has been observed early in infection
(∼ from 6 h.p.i), similar to that of Dengue C protein, and
disruption of the nucleocytoplasmic translocation process
reduces the production of infectious particles (Cerutti et al.,
2011).
Nuclear Functions of the Nucleocapsid
Proteins of RNA Viruses
Based on current literature and our understanding of
nucleocytoplasmic traﬃcking in the context of virus infection, it
can be proposed that the nuclear accumulation of nucleocapsid
proteins may serve two functions. Nucleocapsid proteins may
have non-structural roles in modulation of nuclear processes in
order to maximize virus replication or to inhibit IFN induction
and signaling pathways. Alternatively, nucleocapsid proteins
may localize coincidentally to the nucleus/nucleolus due to
molecular mimicry.
Virus Replication
The nuclear/nucleolar translocation of the nucleocapsid protein
is probably most often associated with optimal virus replication.
For example, IBV nucleocapsid redistributes ﬁbrillarin and delays
cytokinesis to divert biosynthetic resources from the dividing
nucleus to the cytoplasm, where viral replication takes place
(Wurm et al., 2001; Chen et al., 2002). The resultant cell cycle
arrest/delay would be conducive to higher virus replication
through both redirection of biosynthetic machinery for viral
replication and delay in cell division. A similar cell cycle arrest
has also been observed in other coronaviruses and may be
a common consequence of the nucleolar localization of the
nucleocapsid protein (Wurm et al., 2001). In nature, these
viruses infect terminally diﬀerentiated epithelial cells which do
not actively divide; it is unclear how the cell cycle modulation
observed in cell culture would be useful in a natural infection.
The nuclear/nucleolar localization of JEV C protein is also
required for optimal virus replication in mammalian cells (Mori
et al., 2005). The importance of the nuclear functions of the
core protein in ﬂavivirus infection is demonstrated by the
inability of some ﬂaviviruses to replicate in enucleated cells
(Kos et al., 1975; Lad et al., 1993). Both the Dengue and
HCV C protein interact with heterogeneous nuclear RNP K,
possibly to regulate host cell transcription, thereby freeing
cellular machinery for viral RNA synthesis (Hsieh et al., 1998;
Chang et al., 2001).
Interferon Antagonism
Nucleocapsid proteins of some RNA viruses function in the
nucleus to inhibit the potent antiviral IFN response. The
innate antiviral response, mediated principally by the action of
Type-I IFNs, is one of the earliest responses of the host to
viral infection (Conzelmann, 2005). Virus speciﬁc intracellular
pathogen associated molecular patterns (e.g., viral RNA or
dsRNA) are recognized by cellular helicases retinoic-acid-
inducible protein I and melanoma-diﬀerentiation-associated
gene 5 (See and Wark, 2008) initiating a cascade of events
resulting in the activation of transcription factors including IFN
response factor 3 (IRF3), nuclear factor (NF) κB and activating
protein 1 that are subsequently transported into the nucleus
to activate transcription of IFN-β. IFN-β mRNA is exported
out of the nucleus, where it is translated into protein which is
secreted from the cell to induce a secondary cellular response
in an autocrine and paracrine manner, by binding to the IFN-
α/β receptor. This in turn leads to activation of a second
cascade of events involving several eﬀectors and transcription
factors such as the STAT proteins. These proteins translocate
into the nucleus, interact with IFN-sensitive response elements
and activate transcription of a broad range of IFN stimulated
genes (ISG). The ISG products mount a concerted immune
response which prevents virus replication (See and Wark,
2008).
As mentioned already, MV nucleocapsid protein inhibits
the nuclear translocation of STATs, causing disruption of
the IFN-α/β and IFN-γ signaling pathways (Takayama et al.,
2012). Coronavirus nucleocapsid protein has been shown to
have potent IFN antagonistic activity; however, the mechanism
varies in diﬀerent virus species. The MHV nucleocapsid
protein interferes with the IFN induced 2′-5′ oligoadenylate
synthetase RNase L pathway and can functionally replace
the IFN antagonist activity of E3L protein in a recombinant
vaccinia virus (Ye et al., 2007), thus contributing to the
IFN resistance exhibited by MHV (Rose and Weiss, 2009).
The SARS-CoV nucleocapsid protein is also a potent IFN
antagonist, however, it is mostly cytoplasmic (discussed above)
and inhibits IFN production (Kopecky-Bromberg et al., 2007)
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rather than IFN signaling. Similar to SARS-CoV, the porcine
epidemic diarrhea virus nucleocapsid protein inhibits IFN
production via direct interaction with TRAF-associated NF-kB
activator binding kinase (TBK1), thus interfering with the
TBK1 mediated phosphorylation of IRF3, required for IRF3
dimerization and subsequent nuclear localization, which is
critical to IFN activation (Zhao, 2013; Ding et al., 2014b).
Nucleocapsid protein’s IFN antagonist activity may not always be
dependent on its nuclear localization.
Molecular Mimicry
The nucleocapsid protein generally has Lysine (K) or Arginine
(R) rich RNA binding domains (to associate with viral genome),
which resemble nuclear transport signals and these motifs
may serve the dual purpose of mediating nuclear localization
of nucleocapsid protein coincidental to their main function.
This is the basis for molecular mimicry, wherein the K/R-
rich RNA binding domains resembling NLS/NoLS motifs, allow
the nucleocapsid protein to be transported into the nucleus
by cellular nucleocytoplasmic traﬃcking machinery (Rowland
and Yoo, 2003). Other possibilities include association with
ribosomal proteins, and passive diﬀusion. Association with
ribosomal proteins in the cytoplasm might result in nucleocapsid
protein being coincidentally translocated into the nucleolus,
where the ribosomal proteins associate with rRNA to form
ribosomal subunits (Tijms et al., 2002). Although termed
“coincidental,” nuclear localization of nucleocapsid protein might
serve a speciﬁc viral purpose by maintaining the nucleocapsid
protein:ribonucleotides stoichiometry in the cytoplasm. This is
essential in order to produce functional genomes, such that
transient nuclear/nucleolar localization of excess nucleocapsid
protein can be a means to keep the appropriate concentration
of nucleocapsid protein molecules in the cytoplasm (Tijms et al.,
2002).
Potential for Future Therapeutic
Strategies
As discussed above, N/NC/C proteins of cytoplasmic RNA
viruses have an important nuclear role in addition to their
essential cytoplasmic role in virus assembly. This presents an
opportunity for a broad ranging antiviral that may inhibit
nuclear transport of these proteins, thus indirectly reducing virus
assembly, leading to reduced infectious virus production and
hence reduced disease. New generations of speciﬁc inhibitors of
nuclear export (SINE) are well characterized compounds that
have low toxicity and good bioavailability and are currently
in clinical trials for various cancers and could potentially be
re-purposed for virus infections (Azmi et al., 2013a,b; Gao
et al., 2014). However, targeting host–pathogen interface is
preferable to targeting of cellular processes. Elucidation of
the NLS/NoLS motifs of the nucleocapsid proteins and their
mechanism of localization should identify interactions that
may be modeled for development of small molecule inhibitors
(Lundberg et al., 2013); indeed, given the vast array of small
molecule inhibitors currently available, it may be possible
to identify inhibitors via high throughput screening assays
(Wagstaﬀ et al., 2011). Ivermectin and Mifepristone are two
such compounds shown to reduce infectious virus titers of
several viruses that exploit host nuclear transport machinery (Tay
et al., 2013). Determination of the NLS/NoLS also presents an
opportunity for development of attenuated vaccine candidates.
Speciﬁc mutations that disable the nuclear/nucleolar localization
function, without hampering the cytoplasmic function of
nucleocapsid proteins, should result in viruses that replicate,
albeit to lesser degree due to reduced ability to inhibit
antiviral responses; mutating the NLS of RSV M protein
leads to reduced replication ﬁtness, supporting the viability
of such an approach (Ghildyal et al., 2009). That targeting
the nucleocapsid protein for attenuation is a viable strategy
has been demonstrated for VSV (Sato et al., 2011).
Summary
Structural proteins of several enveloped RNA viruses localize
into the nucleus and/or nucleolus at certain times of the viral
life cycle, primarily early in infection. Their nucleocytoplasmic
transport is facilitated by nuclear localization/export signals in
association with cellular transport proteins. The nucleocapsid
protein is a major structural protein of enveloped RNA viruses
which serves a structural function in virus assembly. Its function
includes protecting the genome against ribonucleases, regulating
the ﬁdelity of the replication template, forming the replication
complex, and packaging of the genomic RNA for assembly,
budding, and particle release. The nucleocapsid proteins
of several viruses belonging to Coronaviridae, Arteriviridae,
Flaviviridae, and Paramyxoviridae possess NLS/NoLS and
transiently localize into the nucleus/nucleolus during the viral
life cycle. In some cases the nuclear localization appears to
support viral proliferation by interfering with the host’s immune
response or other mechanisms including maintaining the balance
of nucleocapsid protein:RNA molecules for optimum production
of the functional viral genome. As such, the nuclear localization
of nucleocapsid protein of enveloped RNA viruses has potential
as a target for the development of live-attenuated vaccines or
antiviral drugs, as inhibition of its nuclear localization could
negatively impact on the production of infectious viral particles
and cell-to-cell spread.
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